Buto Corp

Buto Corp, located in Davis, CA, is dedicated to developing potent inhibitors of inflammation that play a key role in driving Alzheimer’s Disease and Fibrotic Disease. Their unique therapeutic approach focuses on blocking inflammation of the innate immune system, targeting the Shc protein and pathway. Buto's molecules have shown promising results in ameliorating Alzheimer’s Disease in mouse models and benefiting human lung fibrosis and other fibrotic conditions in various animal models.

Their research highlights the impact of repetitive injury in inflaming immune cells, leading to detrimental effects in Alzheimer’s Disease and fibrosis. By inhibiting the Shc protein, Buto aims to address the root cause of inflammation in these diseases, offering a potential avenue for therapeutic intervention. Buto Corp is committed to bringing about positive change in the field of neurodegenerative and fibrotic diseases through innovative research and targeted drug development.

Generated from the website content